Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIDESTEP: Ertapenem vs Piperacillin/Tazobactam in Diabetic Foot Infections
NCT00229112Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertapenem in diabetic foot infection (DFI), sponsored by Merck & Co.. Started Apr 2001; status: completed.
02
Drugs
ertapenem
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT00229112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229112.